Index of reports
> Disability (20)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Optimark (Gadoversetamide) disability. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Optimark side effects in 54 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02
Patient: 54 year old male
Reactions: Pruritus, Muscle Contractions Involuntary, Pain, Abasia, Neuropathic Ulcer, Erythema, Muscle Rigidity, Neuropathy Peripheral, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Fibrosis, Muscle Spasms, Excoriation, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Emotional Distress, Arthralgia, Mobility Decreased
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2000-11-29
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2000-12-12
End date: 2000-12-12
Optimark
Magnevist
Omniscan
Other drugs received by patient: Epoetin Alfa; Phoslo; Lorazepam; Misoprostol; Cefazolin Sodium; Vitamin E; Vitamin D; Amiodarone Hydrochloride; Lansoprazole; Humulin R; Calcium Acetate; Verapamil HCL; Atacand HCT; Minoxidil; Cytotec
Possible Optimark side effects in female
Reported by a physician from United States on 2012-06-18
Patient: female
Reactions: Abdominal Pain, Pulmonary Hypertension, Pruritus, Contusion, Nocturia, Hyperhidrosis, Cardiomegaly, Pericardial Effusion, Off Label Use, Biliary Dilatation, Melanocytic Naevus, Open Wound, Nephrogenic Systemic Fibrosis, Joint Swelling, Impaired Gastric Emptying, Mobility Decreased, Renal Transplant, Wheezing, Chills, Morganella Infection, Polyuria, Constipation, Splenic Infarction, Gastritis, Myalgia, Weight Increased, Fatigue, Hepatomegaly, Skin Ulcer, Dizziness, Pleural Effusion, Musculoskeletal Stiffness, Cholecystitis, Splenomegaly, Decreased Appetite, Device Related Sepsis, Nausea, Muscular Weakness, Rash, Hypercoagulation, Cerebrovascular Accident, Ascites, Arthralgia, Bradycardia, Renal Tubular Necrosis, Proteus Infection
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Optimark
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-08-02
End date: 2006-08-02
Optimark
Dosage: 20 ml, single
Indication: Angiogram
Start date: 2006-08-05
End date: 2006-08-05
Other drugs received by patient: Metoclopramide; Procardia XL; Epogen; Lisinopril; Renagel; Colace; Micardis; Terazosin HCL; Calcium Acetate; Novolog; Levaquin; Metoprolol Succinate Extended Release; Flagyl
Possible Optimark side effects in 54 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-14
Patient: 54 year old male
Reactions: Abasia, Pain, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Emotional Distress, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Fibrosis, Mobility Decreased
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Magnevist
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2000-12-12
End date: 2000-12-12
Optimark
Omniscan
Possible Optimark side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-11
Patient: male, weighing 70.0 kg (154.0 pounds)
Reactions: Nephrogenic Systemic Fibrosis
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Prohance
Indication: Renal Mass
Start date: 2003-07-03
End date: 2003-07-03
Omniscan
Indication: Liver Disorder
Start date: 2004-07-13
End date: 2004-07-13
Omniscan
Indication: Neck Pain
Start date: 2004-07-13
End date: 2004-07-13
Omniscan
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2004-07-13
End date: 2004-07-13
Prohance
Indication: Renal Scan
Start date: 2003-07-03
End date: 2003-07-03
Omniscan
Indication: Osteomyelitis
Start date: 2004-07-13
End date: 2004-07-13
Contrast Media
Indication: Decubitus Ulcer
Start date: 2005-04-14
End date: 2005-04-14
Magnevist
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-04-14
End date: 2005-04-14
Contrast Media
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-04-14
End date: 2005-04-14
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2004-07-13
End date: 2004-07-13
Multihance
Indication: Diagnostic Procedure
Optimark
Omniscan
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2004-10-15
End date: 2004-10-15
Other drugs received by patient: Plavix; Iron; Clonidine; Calcitriol; Proamatine; Epogen; Renvela; Cozaar; Calcium Carbonate; Metoprolol Tartrate; Sensipar; Rena-Vite; Phoslo; Hectorol; Renagel; Amlodipine; Fosrenol; Lisinopril; Foltx
Possible Optimark side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-06
Patient: male, weighing 70.0 kg (154.0 pounds)
Reactions: Pruritus, Hyperkeratosis, Pain, Skin Burning Sensation, Skin Hyperpigmentation, Erythema, Joint Stiffness, Skin Discolouration, Joint Range of Motion Decreased, Skin Lesion, Fibrosis, Extremity Contracture, General Physical Health Deterioration, Muscular Weakness, Nephrogenic Systemic Fibrosis, DRY Skin, Hypoaesthesia, Skin Induration, Deformity, Skin Tightness, Paraesthesia, Skin Plaque, Rash Macular, Gait Disturbance, Scar, Mobility Decreased
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2005-04-14
End date: 2005-04-14
Omniscan
Dosage: 15 ml, unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2004-10-15
End date: 2004-10-15
Prohance
Dosage: 17 ml, once
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2003-07-03
End date: 2003-07-03
Magnevist
Omniscan
Dosage: 30 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2004-07-13
End date: 2004-07-13
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-04-14
End date: 2005-04-14
Omniscan
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Optimark
Multihance
Other drugs received by patient: Calcitriol; Plavix; Fosrenol; Sensipar; Clonidine; Renvela; Rena-Vite; Calcium Carbonate; Metoprolol Tartrate; Renagel; Cozaar; Phoslo; Epogen; Hectorol; Iron; Amlodipine; Lisinopril; Proamatine; Foltx
Possible Optimark side effects in female
Reported by a physician from United States on 2012-05-04
Patient: female
Reactions: Pulmonary Hypertension, Abdominal Pain, Renal Transplant, Chills, Hyperhidrosis, Cardiomegaly, Splenic Infarction, Pericardial Effusion, Gastritis, Weight Increased, Off Label Use, Hepatomegaly, Biliary Dilatation, Pleural Effusion, Musculoskeletal Stiffness, Cholecystitis, Splenomegaly, Decreased Appetite, Device Related Sepsis, Nausea, Nephrogenic Systemic Fibrosis, Hypercoagulation, Cerebrovascular Accident, Ascites, Renal Tubular Necrosis, Bradycardia, Impaired Gastric Emptying, Proteus Infection
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Optimark
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-08-02
End date: 2006-08-02
Optimark
Dosage: 20 ml, single
Indication: Angiogram
Start date: 2006-08-05
End date: 2006-08-05
Other drugs received by patient: Lisinopril; Novolog; Metoclopramide; Procardia XL; Flagyl; Levaquin; Colace; Metoprolol Succinate Extended Release; Terazosin HCL; Micardis; Renagel; Calcium Acetate; Epogen
Possible Optimark side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-02
Patient: male, weighing 77.6 kg (170.6 pounds)
Reactions: Femoral Arterial Stenosis, Headache, Cyst, Pulmonary Granuloma, Tunnel Vision, Malaise, Nodule, Temperature Intolerance, Back Pain, Actinic Keratosis, Prostate Cancer, Coronary Artery Disease, Nephrogenic Systemic Fibrosis, Helicobacter Infection, Neurodermatitis, Hypoaesthesia, Stress, Activities of Daily Living Impaired, Ventricular Tachycardia, Ear Pain, Fall, Poor Quality Sleep, Fatigue, Basal Cell Carcinoma, Dizziness, Acute Myocardial Infarction, Vomiting, Supraventricular Extrasystoles, Nausea, Squamous Cell Carcinoma, Bundle Branch Block Left, Rash, Ascites, Carotid Artery Stenosis, Meniscus Lesion, Diarrhoea, Atrioventricular Block, Gait Disturbance, Arthritis, Asthenia, Infection
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Optimark
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-12-15
End date: 2005-12-15
Omniscan
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2004-09-23
Other drugs received by patient: Simvastatin; Diovan; Renal Softgel; Minoxidil
Possible Optimark side effects in female
Reported by a physician from United States on 2012-05-01
Patient: female
Reactions: Abdominal Pain, Orthostatic Hypotension, Pulmonary Embolism, Osteomyelitis, Headache, Ingrowing Nail, Staphylococcal Bacteraemia, Arteriosclerosis, Back Pain, Localised Infection, Pneumonia, Anaemia, Hypotension, Helicobacter Infection, Nephrogenic Systemic Fibrosis, Nail Hypertrophy, Osteopenia, Osteosclerosis, Iliac Artery Stenosis, Dehydration, Impaired Gastric Emptying, Spinal Column Stenosis, Pain, Fall, Hypoacusis, Skin Ulcer, Intervertebral Discitis, Chest Pain, Arteriovenous Fistula Thrombosis, Blood Pressure Increased, Vomiting, Nausea, Syncope, Diarrhoea, Sepsis, Retroperitoneal Lymphadenopathy, Spinal Osteoarthritis, Deep Vein Thrombosis, Infectious Peritonitis
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Optimark
Dosage: unk, single
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-03-03
End date: 2006-03-03
Multihance
Dosage: 15 ml, single
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2008-07-30
End date: 2008-07-30
Gadolinium
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2010-01-01
End date: 2010-01-01
Optimark
Indication: Angiogram
Omniscan
Dosage: 40 ml, single
Indication: Angiogram
Start date: 2007-02-06
End date: 2007-02-06
Multihance
Dosage: 17 ml, single
Start date: 2009-11-19
End date: 2009-11-19
Possible Optimark side effects in 43 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-30
Patient: 43 year old male, weighing 118.0 kg (259.6 pounds)
Reactions: Pain in Extremity, General Physical Health Deterioration, Skin Induration, Nephrogenic Systemic Fibrosis, Deformity, Skin Tightness, Emotional Distress, Anxiety, Skin Discolouration, Fibrosis, Depression, Mobility Decreased, Scar
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Omniscan
Dosage: 20 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-04-25
End date: 2006-04-25
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Dosage: 20 ml, once
Start date: 2006-05-21
End date: 2006-05-21
Other drugs received by patient: Nephrocaps; Losartan Potassium; Aldactone; Insulin; Albumin (Human); Cardizem; Zemplar; Procardia XL; Aranesp; Catapres; Procrit; Phoslo
Possible Optimark side effects in male
Reported by a lawyer from United States on 2012-04-19
Patient: male
Reactions: Femoral Arterial Stenosis, Headache, Cyst, Pulmonary Granuloma, Tunnel Vision, Malaise, Nodule, Actinic Keratosis, Back Pain, Prostate Cancer, Coronary Artery Disease, Nephrogenic Systemic Fibrosis, Hypoaesthesia, Helicobacter Infection, Neurodermatitis, Stress, Activities of Daily Living Impaired, Ventricular Tachycardia, Ear Pain, Fall, Poor Quality Sleep, Fatigue, Basal Cell Carcinoma, Dizziness, Acute Myocardial Infarction, Squamous Cell Carcinoma, Nausea, Supraventricular Extrasystoles, Bundle Branch Block Left, Rash, Ascites, Carotid Artery Stenosis, Meniscus Lesion, Diarrhoea, Atrioventricular Block, Gait Disturbance, Asthenia, Arthritis, Infection
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Optimark
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-12-15
End date: 2005-12-15
Omniscan
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2004-09-23
Other drugs received by patient: Minoxidil; Simvastatin; Diovan; Renal Softgel
Possible Optimark side effects in male
Reported by a lawyer from United States on 2012-04-02
Patient: male
Reactions: Femoral Arterial Stenosis, Headache, Cyst, Pulmonary Granuloma, Tunnel Vision, Malaise, Nodule, Actinic Keratosis, Back Pain, Prostate Cancer, Coronary Artery Disease, Hypoaesthesia, Nephrogenic Systemic Fibrosis, Helicobacter Infection, Neurodermatitis, Stress, Activities of Daily Living Impaired, Ventricular Tachycardia, Ear Pain, Fall, Poor Quality Sleep, Fatigue, Basal Cell Carcinoma, Dizziness, Acute Myocardial Infarction, Nausea, Squamous Cell Carcinoma, Supraventricular Extrasystoles, Bundle Branch Block Left, Rash, Ascites, Meniscus Lesion, Carotid Artery Stenosis, Diarrhoea, Atrioventricular Block, Gait Disturbance, Arthritis, Asthenia, Infection
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Omniscan
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2004-09-23
Optimark
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-12-15
End date: 2005-12-15
Other drugs received by patient: Renal Softgel; Diovan; Simvastatin; Minoxidil
Possible Optimark side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-05
Patient: female, weighing 78.7 kg (173.1 pounds)
Reactions: Pain, Abasia, Skin Induration, Nephrogenic Systemic Fibrosis, Deformity, Skin Tightness, Emotional Distress, Anxiety, Skin Discolouration, Fibrosis, Coordination Abnormal, Mobility Decreased
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Magnevist
Indication: Imaging Procedure
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2008-02-25
End date: 2008-02-25
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2004-06-04
End date: 2004-06-04
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2002-08-24
End date: 2002-08-24
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2004-07-16
End date: 2004-07-16
Optimark
Indication: Imaging Procedure
Multihance
Indication: Imaging Procedure
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2005-05-25
End date: 2005-05-25
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2008-06-04
End date: 2008-06-04
Omniscan
Indication: Imaging Procedure
Prohance
Indication: Imaging Procedure
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2004-05-17
End date: 2004-05-17
Other drugs received by patient: Venofer; Aranesp; Clonidine; Metoprolol Succinate; Altace; Coumadin; Atenolol; Renagel; Enalapril Maleate; Epogen; Norvasc; Renvela
Possible Optimark side effects in male
Reported by a physician from United States on 2011-12-02
Patient: male
Reactions: Transplant Failure, Cyst, Catheter Placement, Basal Cell Carcinoma, Skin Cancer, Nodule, Salivary Gland Operation, Actinic Keratosis, Squamous Cell Carcinoma, Prostate Cancer, Nephrogenic Systemic Fibrosis, Neurodermatitis, Stress, Meniscus Lesion, Cardiac Pacemaker Insertion, Activities of Daily Living Impaired, Gait Disturbance, Asthenia, Arthritis, Infection
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Omniscan
Dosage: unk
Start date: 2004-09-23
Optimark
Dosage: unk
Start date: 2005-12-15
End date: 2005-12-15
Optimark
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2001-11-01
Omniscan
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 1998-06-01
Other drugs received by patient: Diovan; Minoxidil; Renal Softgel; Simvastatin
Possible Optimark side effects in 42 year old male
Reported by a consumer/non-health professional from United States on 2011-11-28
Patient: 42 year old male
Reactions: Joint Contracture, Pain, General Physical Health Deterioration, Skin Induration, Nephrogenic Systemic Fibrosis, Emotional Distress, Anxiety, Musculoskeletal Stiffness, Gait Disturbance, Fibrosis, Asthenia, Extremity Contracture, Scar, Mobility Decreased
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Magnevist
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Vicodin; Pancrelipase; Novolog; Antineoplastic Agents; Fexofenadine; Diclofenac Sodium ER; Lantus; Omega-3 Fatty Acids; Labetalol HCL; Ranitidine; Glipizide; Glucagon; Cartia XT; Mycophenolate Mofetil (Cellcept); Prograf; Prednisone TAB; Therems; Paracetamol W / Tramadol Hydrochloride
Possible Optimark side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-15
Patient: 42 year old male, weighing 81.0 kg (178.2 pounds)
Reactions: Skin Exfoliation, Joint Contracture, Pain, Post Inflammatory Pigmentation Change, Neuropathic Arthropathy, Stasis Dermatitis, Anhedonia, Joint Range of Motion Decreased, Skin Ulcer, Oedema, Rash Generalised, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, DRY Skin, Skin Induration, Skin Tightness, Rash Macular, Anxiety, Emotional Distress, Xerosis
Adverse event resulted in: death, disablity
Drug(s) suspected as cause:
Magnevist
Dosage: 20 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 1999-08-18
End date: 1999-08-18
Magnevist
Omniscan
Omniscan
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2005-12-06
End date: 2005-12-06
Optimark
Dosage: 30 ml, once
Start date: 2006-03-23
End date: 2006-03-23
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Dosage: 20 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-09-01
End date: 2005-09-01
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Brain
Omniscan
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-05-16
End date: 2006-05-16
Other drugs received by patient: Levothroid; Lotrel; Epogen; Lanoxin; Phoslo; Imuran; Ascorbic Acid W / Folic Acid / Iron / Vitamin B12; Protonix; Acyclovir; Morphine; Reglan; Pravachol; Neurontin; Quinine Sulfate; Imodium; Gastromark; Avinza; Niferex; Coumadin; Lantus; Novolog; Rena-Vite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Aciphex; Nephrocaps; Cyclosporine
Possible Optimark side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-10
Patient: female, weighing 78.7 kg (173.1 pounds)
Reactions: Pain, Abasia, Nephrogenic Systemic Fibrosis, Skin Induration, Deformity, Skin Tightness, Emotional Distress, Anxiety, Skin Discolouration, Coordination Abnormal, Fibrosis, Mobility Decreased
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2005-05-25
End date: 2005-05-25
Optimark
Indication: Imaging Procedure
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2002-08-24
End date: 2002-08-24
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2008-02-25
End date: 2008-02-25
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2004-07-16
End date: 2004-07-16
Multihance
Indication: Imaging Procedure
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2008-06-04
End date: 2008-06-04
Magnevist
Indication: Imaging Procedure
Prohance
Indication: Imaging Procedure
Omniscan
Indication: Imaging Procedure
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2004-05-17
End date: 2004-05-17
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2004-06-04
End date: 2004-06-04
Other drugs received by patient: Metoprolol; Renagel; Coumadin; Enalapril Maleate; Clonidine; Altace; Atenolol; Renvela; Epogen; Aranesp; Norvasc; Venofer
Possible Optimark side effects in 73 year old male
Reported by a consumer/non-health professional from United States on 2011-11-08
Patient: 73 year old male
Reactions: Pain, Joint Contracture, Skin Induration, Nephrogenic Systemic Fibrosis, Skin Tightness, Anxiety, Emotional Distress, Anhedonia, Joint Range of Motion Decreased, Injury, Mobility Decreased
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Omniscan
Dosage: 20cc
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2002-07-15
End date: 2002-07-15
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Angiogram
Gadolinium IN Unspecified Drug
Dosage: 20cc injected
Start date: 2002-07-15
Omniscan
Indication: Angiogram
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Angiogram
Start date: 2001-05-14
Multihance
Indication: Angiogram
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Angioplasty
Start date: 2004-06-21
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium IN Unspecified Drug
Indication: Imaging Procedure
Prohance
Indication: Angiogram
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2000-05-26
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2004-11-06
Magnevist
Indication: Angiogram
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 1999-07-10
End date: 1999-07-10
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2002-07-18
Gadolinium IN Unspecified Drug
Dosage: 30cc
Start date: 2003-11-20
Other drugs received by patient: Flonase; Plavix; Metoprolol; Zocor; Coumadin; Singulair; Renagel; Sertraline Hydrochloride; Furosemide; Procrit; Allegra; Procrit; Iron [citric Acid,ferrous Sulfate]; Valsartan; Vitaplex; Actos; Glipizide; Ramipril
Possible Optimark side effects in 73 year old male
Reported by a lawyer from United States on 2011-11-08
Patient: 73 year old male
Reactions: Pain, Joint Contracture, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Emotional Distress, Anxiety, Anhedonia, Joint Range of Motion Decreased, Injury, Mobility Decreased
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Multihance
Indication: Angiogram
Prohance
Indication: Angiogram
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2000-05-26
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium IN Unspecified Drug
Dosage: 20cc injected
Start date: 2002-07-15
Gadolinium IN Unspecified Drug
Dosage: 30cc
Start date: 2003-11-20
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2002-07-18
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Angiogram
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Angioplasty
Start date: 2004-06-21
Magnevist
Indication: Angiogram
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Angiogram
Omniscan
Dosage: 20cc
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2002-07-15
End date: 2002-07-15
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 1999-07-10
End date: 1999-07-10
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Angiogram
Start date: 2001-05-14
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2004-11-06
Gadolinium IN Unspecified Drug
Indication: Imaging Procedure
Other drugs received by patient: Procrit; Coumadin; Plavix; Actos; Zocor; Renagel; Glipizide; Ramipril; Procrit; Singulair; Allegra; Sertraline Hydrochloride; Flonase; Vitaplex; Iron [citric Acid,ferrous Sulfate]; Furosemide; Valsartan; Metoprolol
Possible Optimark side effects in 42 year old male
Reported by a lawyer from United States on 2011-10-20
Patient: 42 year old male
Reactions: Pain, Joint Contracture, General Physical Health Deterioration, Skin Induration, Nephrogenic Systemic Fibrosis, Emotional Distress, Anxiety, Musculoskeletal Stiffness, Fibrosis, Gait Disturbance, Asthenia, Scar, Mobility Decreased, Extremity Contracture
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Other drugs received by patient: Prograf; Glucagon; Cartia XT; Ranitidine; Antineoplastic Agents; Diclofenac Sodium ER; Vicodin; Mycophenolate Mofetil (Cellcept); Omega-3 Fatty Acids; Novolog; Lantus; Pancrelipase; Glipizide; Fexofenadine; Labetalol HCL; Prednisone; Paracetamol W / Tramadol Hydrochloride; Therems
Possible Optimark side effects in 43 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-10
Patient: 43 year old male, weighing 118.0 kg (259.6 pounds)
Reactions: Pain in Extremity, General Physical Health Deterioration, Skin Induration, Nephrogenic Systemic Fibrosis, Deformity, Skin Tightness, Emotional Distress, Anxiety, Skin Discolouration, Depression, Fibrosis, Mobility Decreased, Scar
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Dosage: 20 ml, once
Start date: 2006-05-21
End date: 2006-05-21
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Dosage: 20 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-04-25
End date: 2006-04-25
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Insulin [insulin]; Zemplar; Cardizem; Losartan Potassium; Albumin (Human); Aranesp; Phoslo; Catapres; Nephrocaps; Procardia XL; Procrit; Aldactone
|